Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Velzen

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Proteome Research|April 21, 2009
Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolitesEwoud J J van Velzen, Johan A Westerhuis, John P M van Duynhoven, et al.
Trials|July 27, 2022
The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of strokeSuk Fun Cheng, Twan J van Velzen, John Gregson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Metabolic fate of polyphenols in the human superorganismJohn van Duynhoven, Elaine E Vaughan, Doris M Jacobs, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover studyAnnelies J van Velzen, Joris W F Uges, Harry G M Heijerman, et al.
European Journal of Radiology|October 14, 2023
Application of mask images of contrast-enhanced MR angiography to detect carotid intraplaque hemorrhage in patients with moderate to severe symptomatic and asymptomatic carotid stenosisMohamed Kassem, Soraya S de Kam, Twan J van Velzen, et al.
Leukemia|May 16, 2015
Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumabI S Nijhof, R W J Groen, H M Lokhorst, et al.
Plos One|June 9, 2022
Association between plaque vulnerability and neutrophil extracellular traps (NETs) levels: The Plaque At RISK studyJudith J de Vries, Anouchska S A Autar, Dianne H K van Dam-Nolen, et al.
The Lancet. Neurology|April 19, 2025
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trialSimone J A Donners, Twan J van Velzen, Suk Fun Cheng, et al.
Journal of Neurology|May 27, 2022
Thrombolysis in stroke patients with elevated inflammatory markersValerian L Altersberger, Lukas S Enz, Gerli Sibolt, et al.
American Journal of Human Genetics|June 10, 2023
Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxiasPaulina Cunha, Emilien Petit, Marie Coutelier, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Proteome Research|April 21, 2009
Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolitesEwoud J J van Velzen, Johan A Westerhuis, John P M van Duynhoven, et al.
Trials|July 27, 2022
The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of strokeSuk Fun Cheng, Twan J van Velzen, John Gregson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Metabolic fate of polyphenols in the human superorganismJohn van Duynhoven, Elaine E Vaughan, Doris M Jacobs, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover studyAnnelies J van Velzen, Joris W F Uges, Harry G M Heijerman, et al.
European Journal of Radiology|October 14, 2023
Application of mask images of contrast-enhanced MR angiography to detect carotid intraplaque hemorrhage in patients with moderate to severe symptomatic and asymptomatic carotid stenosisMohamed Kassem, Soraya S de Kam, Twan J van Velzen, et al.
Leukemia|May 16, 2015
Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumabI S Nijhof, R W J Groen, H M Lokhorst, et al.
Plos One|June 9, 2022
Association between plaque vulnerability and neutrophil extracellular traps (NETs) levels: The Plaque At RISK studyJudith J de Vries, Anouchska S A Autar, Dianne H K van Dam-Nolen, et al.
The Lancet. Neurology|April 19, 2025
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trialSimone J A Donners, Twan J van Velzen, Suk Fun Cheng, et al.
Journal of Neurology|May 27, 2022
Thrombolysis in stroke patients with elevated inflammatory markersValerian L Altersberger, Lukas S Enz, Gerli Sibolt, et al.
American Journal of Human Genetics|June 10, 2023
Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxiasPaulina Cunha, Emilien Petit, Marie Coutelier, et al.
Pageof 5